DTIL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
DTIL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. Precision BioSciences's Degree of Operating Leverage for the quarter that ended in Mar. 2025 was -1.38. The higher Degree of Operating Leverage, the higher operating risk the company will take.
The industry rank for Precision BioSciences's Degree of Operating Leverage or its related term are showing as below:
The historical data trend for Precision BioSciences's Degree of Operating Leverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Precision BioSciences Annual Data | |||||||||||||||||
Trend | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||
Degree of Operating Leverage | Get a 7-Day Free Trial | 1.99 | -0.19 | -2.63 | -0.60 | -2.98 |
Precision BioSciences Quarterly Data | ||||||||||||||||||||
Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | |
Degree of Operating Leverage | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-0.88 | -1.54 | -2.96 | -2.98 | -1.38 |
For the Biotechnology subindustry, Precision BioSciences's Degree of Operating Leverage, along with its competitors' market caps and Degree of Operating Leverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Precision BioSciences's Degree of Operating Leverage distribution charts can be found below:
* The bar in red indicates where Precision BioSciences's Degree of Operating Leverage falls into.
Precision BioSciences's Degree of Operating Leverage for the quarter that ended in Mar. 2025 is calculated as:
Degree of Operating Leverage | = | % Change in EBIT** | / | % Change in Revenue |
= | ( -20.424 (Mar. 2025) / -17.707 (Mar. 2024) - 1 ) | / | ( 51.141 (Mar. 2025) / 57.531 (Mar. 2024) - 1 ) | |
= | 0.1534 | / | -0.1111 | |
= | -1.38*** |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** TTM data of EBIT and Revenue was used to calculate Degree of Operating Leverage.
*** Please be aware that the Degree of Operating Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Precision BioSciences (NAS:DTIL) Degree of Operating Leverage Explanation
Degree of Operating Leverage (DOL) is a leverage ratio that measures the sensitivity of a company’s operting income, also referred to as Earnings Before Interest and Taxes (EBIT), to fluctuations in its Revenue. DOL is a method used to quantify a company’s operating risk. This risk is related to the company's structure of variable costs and fixed costs. Since the fixed costs do not allow the company to adjust the operating costs, the operating risk rises with a higher fixed-to-variable costs proportion.
A high Degree of Operating Leverage indicates that the company’s fixed costs exceed its variable costs. By increasing the sales, the company can earn more profits. In addition, the company must be able to maintain relatively high sales to cover all fixed costs.
Be Aware
The use of operating leverage varies across different industries and business sectors, and the application of Degree of Operating Leverage (DOL) should be adjusted accordingly.
Thank you for viewing the detailed overview of Precision BioSciences's Degree of Operating Leverage provided by GuruFocus.com. Please click on the following links to see related term pages.
Melinda Brown | director | 10 HUDSON YARDS, NEW YORK NY 10001 |
Kevin Buehler | director | C/O PRECISION BIOSCIENCES, INC., 302 E. PETTIGREW STREET, SUITE A-100, DURHAM NC 27701 |
Geno J Germano | director | 5 GIRALDA FARMS, MADISON NJ 07940 |
Michael Amoroso | director, officer: President and CEO | 1330 AVENUE OF THE AMERICAS, 33RD FLOOR, NEW YORK NY 10019 |
J. Jefferson Smith | 10 percent owner | C/O PRECISION BIOSCIENCES, INC., 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM NC 27701 |
Dario Scimeca | officer: General Counsel | C/O PRECISION BIOSCIENCES, INC., 302 E. PETTIGREW STREET, SUITE A-100, DURHAM NC 27701 |
John Alexander Kelly | officer: Interim CFO | C/O FOREST LABORATORIES, INC., 909 THIRD AVENUE, NEW YORK NY 10022 |
Alan List | officer: Chief Medical Officer | C/O PRECISION BIOSCIENCES, INC., 302 EAST PETTIGREW STREET, DURHAM NC 27701 |
Ag Novartis | 10 percent owner | LICHTSTRASSE 35, BASEL V8 CH 4056 |
Pharma Ag Novartis | 10 percent owner | LICHTSTRASSE 35, CH-4002, BASEL V8 |
Derek Jantz | director, 10 percent owner, officer: Chief Scientific Officer | C/O PRECISION BIOSCIENCES, INC., 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM NC 27701 |
Shari Lisa Pire | director | C/O PRECISION BIOSCIENCES, INC., 302 EAST PETTIGREW STREET, DURHAM NC 27701 |
Samuel C. Wadsworth | director | C/O DIMENSION THERAPEUTICS, INC., 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139 |
David S. Thomson | officer: Chief Development Officer | C/O PRECISION BIOSCIENCES, INC., 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM NC 27701 |
Stanley Frankel | director | C/O PRECISION BIOSCIENCES, INC., 302 EAST PETTIGREW STREET, DURHAM NC 27701 |
From GuruFocus
By Business Wire • 04-15-2025
By Business Wire • 01-09-2025
By Business Wire • 05-08-2025
By GuruFocus News • 05-15-2025
By Business Wire • 04-01-2025
By Business Wire • 03-20-2025
By Business Wire • 04-29-2025
By GuruFocus News • 05-15-2025
By GuruFocus News • 05-14-2025
By Business Wire • 05-15-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.